These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10873984)

  • 1. Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy.
    Cantón A; Burgos R; Hernández C; Mateo C; Segura RM; Mesa J; Simó R
    Br J Ophthalmol; 2000 Jul; 84(7):732-5. PubMed ID: 10873984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders.
    Katsura Y; Okano T; Noritake M; Kosano H; Nishigori H; Kado S; Matsuoka T
    Diabetes Care; 1998 Oct; 21(10):1759-63. PubMed ID: 9773744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: a case-control study.
    Simó R; Vidal MT; García-Arumí J; Carrasco E; García-Ramírez M; Segura RM; Hernández C
    Diabetes Res Clin Pract; 2006 Jan; 71(1):36-44. PubMed ID: 16029908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreous levels of hepatocyte growth factor/scatter factor and vascular cell adhesion molecule-1 in the vitreous fluid of diabetic patients with proliferative retinopathy.
    Hernández C; Carrasco E; García-Arumí J; Maria Segura R; Simó R
    Diabetes Metab; 2004 Sep; 30(4):341-6. PubMed ID: 15525877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
    Burgos R; Simó R; Audí L; Mateo C; Mesa J; García-Ramírez M; Carrascosa A
    Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy.
    Hernández C; Lecube A; Segura RM; Sararols L; Simó R
    Diabet Med; 2002 Aug; 19(8):655-60. PubMed ID: 12147146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreous leptin concentrations in patients with proliferative diabetic retinopathy.
    Hernández C; Lecube A; Castellanos JM; Segura RM; Garat M; García-Arumí J; Simó R
    Retina; 2004 Feb; 24(1):30-5. PubMed ID: 15076941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.
    Hernández C; Burgos R; Cantón A; García-Arumí J; Segura RM; Simó R
    Diabetes Care; 2001 Mar; 24(3):516-21. PubMed ID: 11289478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-paralleled increase of hepatocyte growth factor and vascular endothelial growth factor in the eyes with angiogenic and nonangiogenic fibroproliferation.
    Umeda N; Ozaki H; Hayashi H; Kondo H; Uchida H; Oshima K
    Ophthalmic Res; 2002; 34(1):43-7. PubMed ID: 11834884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CORRELATION OF INCREASED INTRAVITREOUS WNT3A WITH VASCULAR ENDOTHELIAL GROWTH FACTOR IN PROLIFERATIVE DIABETIC RETINOPATHY.
    Gao X; Ma K; Lu N; Hong T; Xu Y; Peng X
    Retina; 2016 Apr; 36(4):812-8. PubMed ID: 26418446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
    Deng J; Wu DZ; Gao R
    Yan Ke Xue Bao; 1999 Mar; 15(1):17-21. PubMed ID: 12579655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in vitreous concentrations of human hepatocyte growth factor (hHGF) in proliferative diabetic retinopathy: implications for intraocular hHGF production.
    Nishimura M; Ikeda T; Ushiyama M; Kinoshita S; Yoshimura M
    Clin Sci (Lond); 2000 Jan; 98(1):9-14. PubMed ID: 10600653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
    Kawashima M; Shoji J; Nakajima M; Kamura Y; Sato Y
    Jpn J Ophthalmol; 2007; 51(2):100-4. PubMed ID: 17401618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.
    Simó R; Hernández C; Segura RM; García-Arumí J; Sararols L; Burgos R; Cantón A; Mesa J
    Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased vitreous concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy.
    Nishimura M; Ikeda T; Ushiyama M; Nanbu A; Kinoshita S; Yoshimura M
    J Clin Endocrinol Metab; 1999 Feb; 84(2):659-62. PubMed ID: 10022434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced concentrations of angiogenesis-related factors in vitreous after vitrectomy in patients with proliferative diabetic retinopathy.
    Yoshida S; Ishikawa K; Matsumoto T; Yoshida A; Ishibashi T; Kono T
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):799-804. PubMed ID: 20135140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Profile of Angiogenic Factors in Vitreous Humor of the Patients with Proliferative Diabetic Retinopathy.
    Yu Y; Zhang J; Zhu R; Zhao R; Chen J; Jin J; Tian Y; Su SB
    Curr Mol Med; 2017 Dec; 17(4):280-286. PubMed ID: 29110608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
    Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.